| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | Director | Mar 15, 2022 | Option Exercise | $15.79 | 1,372 | 21,664 | 94,091 | Mar 17, 2022, 05:50 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Dec 03, 2021 | Buy | $14.43 | 30,000 | 432,876 | 95,463 | Dec 06, 2021, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Aug 15, 2021 | Option Exercise | $26.02 | 4,949 | 128,773 | 74,827 | Aug 17, 2021, 06:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Aug 16, 2021 | Sale | $26.34 | 9,364 | 246,659 | 65,463 | Aug 17, 2021, 06:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Jul 28, 2021 | Sale | $30.00 | 34,332 | 1,029,960 | 321,611 | Jul 30, 2021, 08:57 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Jul 28, 2021 | Sale | $30.15 | 20,000 | 603,000 | 154,302 | Jul 30, 2021, 08:57 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Jul 26, 2021 | Sale | $29.72 | 55,382 | 1,645,953 | 355,943 | Jul 28, 2021, 09:48 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Apr 05, 2021 | Sale | $28.28 | 2 | 57 | 411,325 | Apr 06, 2021, 07:41 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Mar 04, 2021 | Sale | $25.43 | 33,119 | 842,216 | 411,327 | Mar 05, 2021, 08:10 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Feb 01, 2021 | Sale | $25.95 | 33,119 | 859,438 | 444,446 | Feb 03, 2021, 08:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Dec 30, 2020 | Sale | $27.82 | 33,119 | 921,212 | 477,565 | Jan 04, 2021, 08:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Nov 30, 2020 | Sale | $23.85 | 33,119 | 789,888 | 510,684 | Dec 02, 2020, 08:55 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Oct 29, 2020 | Sale | $26.15 | 33,119 | 865,949 | 543,803 | Oct 30, 2020, 08:24 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Sep 28, 2020 | Sale | $26.18 | 33,119 | 867,055 | 576,922 | Sep 30, 2020, 09:21 PM |
Menu